A reason for intermittent fasting to suppress the awakening of dormant breast tumors
暂无分享,去创建一个
Hans V. Westerhoff | Jan Lankelma | Bob Kooi | Klaas Krab | Josephine C. Dorsman | Hans Joenje | H. Westerhoff | J. Lankelma | K. Krab | J. Dorsman | B. Kooi | H. Joenje
[1] L. Kunz-Schughart,et al. Multicellular tumor spheroids: an underestimated tool is catching up again. , 2010, Journal of biotechnology.
[2] F. Bruggeman,et al. Cancer: a Systems Biology disease. , 2006, Bio Systems.
[3] L. Chodosh. Breast cancer: current state and future promise , 2011, Breast Cancer Research.
[4] H. Rabes,et al. Analysis of proliferative compartments in human tumors I. Renal adenocarcinoma , 1979, Cancer.
[5] J. A. Andersen,et al. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. , 1987, British Journal of Cancer.
[6] A. Michalsen,et al. Fasting Therapy for Treating and Preventing Disease - Current State of Evidence , 2013, Complementary Medicine Research.
[7] G. Semenza,et al. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. , 2009, Seminars in cancer biology.
[8] Changhan Lee,et al. Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients , 2011, Oncogene.
[9] H. Pijl. Longevity. The allostatic load of dietary restriction , 2012, Physiology & Behavior.
[10] A. Deutsch,et al. Evolutionary game theory elucidates the role of glycolysis in glioma progression and invasion , 2008, Cell proliferation.
[11] J. Lankelma,et al. A mathematical model of drug transport in human breast cancer. , 2000, Microvascular research.
[12] P. Vaupel,et al. Heterogeneous oxygen partial pressure and pH distribution in C3H mouse mammary adenocarcinoma. , 1981, Cancer research.
[13] J. Folkman. Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.
[14] C. Klein. Framework models of tumor dormancy from patient-derived observations. , 2011, Current opinion in genetics & development.
[15] J. Baak,et al. Prognostic Value of Gene Signatures and Proliferation in Lymph-Node-Negative Breast Cancer , 2014, PloS one.
[16] M. Dewhirst,et al. Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis , 2012, PloS one.
[17] L. H. Gray,et al. The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.
[18] Christoph Kaleta,et al. Combining Metabolic Pathway Analysis with Evolutionary Game Theory. Explaining the occurrence of low-yield pathways by an analytic optimization approach , 2011, Biosyst..
[19] J. Aguirre-Ghiso,et al. Models, mechanisms and clinical evidence for cancer dormancy , 2007, Nature Reviews Cancer.
[20] S. V. Sotirchos,et al. Glucose diffusivity in multicellular tumor spheroids. , 1988, Cancer research.
[21] N. Olea,et al. MCF‐7 breast cancer cells grown as multicellular spheroids in vitro: Effect of 17β‐estradiol , 1992, International journal of cancer.
[22] Archibald Vivian Hill,et al. The Diffusion of Oxygen and Lactic Acid through Tissues , 1928 .
[23] M. Guppy,et al. Metabolic depression: a response of cancer cells to hypoxia? , 2005, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.
[24] Raghu Kalluri,et al. Cancer without disease , 2004, Nature.
[25] R. Jain,et al. Role of tumor vascular architecture in nutrient and drug delivery: an invasion percolation-based network model. , 1996, Microvascular research.
[26] D. Theodorescu,et al. Clinical opportunities and challenges in targeting tumour dormancy , 2013, Nature Reviews Clinical Oncology.
[27] Carlos Caldas,et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. , 2013, The New England journal of medicine.
[28] P. McDonald,et al. Tumor dormancy and the neuroendocrine system: an undisclosed connection? , 2012, Cancer and Metastasis Reviews.
[29] P. Bragado,et al. Metastasis Awakening: Targeting dormant cancer , 2013, Nature Medicine.
[30] I. Tannock,et al. Oxygen diffusion and the distribution of cellular radiosensitivity in tumours. , 1972, The British journal of radiology.
[31] Meyer Js,et al. Subpopulations of breast carcinoma defined by S-phase fraction, morphology, and estrogen receptor content. , 1978 .
[32] T. Copetti,et al. Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration , 2014, Oncogene.
[33] P. Okunieff,et al. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.
[34] I. Tannock,et al. Influence of glucose concentration on growth and formation of necrosis in spheroids derived from a human bladder cancer cell line. , 1986, Cancer research.
[35] W C Black,et al. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. , 1993, The New England journal of medicine.
[36] C. Klein,et al. Parallel progression of primary tumours and metastases , 2009, Nature Reviews Cancer.
[37] Yi Zhou,et al. Catabolic efficiency of aerobic glycolysis: The Warburg effect revisited , 2010, BMC Systems Biology.
[38] Evangelos Simeonidis,et al. Systems Biology: The elements and principles of Life , 2009, FEBS letters.
[39] Lars Holmgren,et al. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.
[40] A Krogh,et al. The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue , 1919, The Journal of physiology.
[41] H. Westerhoff,et al. Metabolic control analysis indicates a change of strategy in the treatment of cancer. , 2010, Mitochondrion.
[42] R. Wolfe,et al. Palmitate and glycerol kinetics during brief starvation in normal weight young adult and elderly subjects. , 1986, The Journal of clinical investigation.
[43] F. Markowetz,et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.
[44] R F Kallman,et al. Migration and internalization of cells and polystyrene microsphere in tumor cell spheroids. , 1982, Experimental cell research.
[45] J. Folkman. Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.
[46] R. Moreno-Sánchez,et al. The bioenergetics of cancer: Is glycolysis the main ATP supplier in all tumor cells? , 2009, BioFactors.
[47] A. Tsirigos,et al. Ketones and lactate “fuel” tumor growth and metastasis , 2010, Cell cycle.
[48] J. Romijn,et al. Progressive alterations in lipid and glucose metabolism during short-term fasting in young adult men. , 1993, The American journal of physiology.
[49] H. Westerhoff,et al. Why does yeast ferment? A flux balance analysis study. , 2010, Biochemical Society transactions.
[50] K. Trott,et al. What is known about tumour proliferation rates to choose between accelerated fractionation or hyperfractionation? , 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[51] P. Leedman,et al. Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. , 2002, The Biochemical journal.
[52] J. Folkman,et al. Heterogeneity of angiogenic activity in a human liposarcoma: a proposed mechanism for "no take" of human tumors in mice. , 2001, Journal of the National Cancer Institute.
[53] J. Lankelma,et al. Doxorubicin gradients in human breast cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[54] Paolo Chiodini,et al. Metabolic Syndrome and Risk of Cancer , 2012, Diabetes Care.
[55] P. Vaupel,et al. l-glutamine: a major substrate for tumor cells in vivo? , 2004, Journal of Cancer Research and Clinical Oncology.